Immunobiology of stiff-person syndrome
- PMID: 18300057
- DOI: 10.1080/08830180701883240
Immunobiology of stiff-person syndrome
Abstract
The two possibilities to explain the pathogenic basis of stiff-person syndrome (SPS) are intrathecal sensitization of GAD65-reactive CD4+T cells and synthesis of GAD65-specific autoantibodies within the CNS [Rakocevic et al., Arch. Neurol. 61: 902-904, 2004]; and peripheral antigen sensitization followed by CNS antigen recognition by autoantibodies that cross the blood-brain barrier. Antigen-specific CD4+ T cells are essential for the generation of high-affinity autoantibodies [Lanzavecchia, Nature 314: 537-539, 1985], but there is no evidence of cellular infiltration in the CNS of SPS patients [Warich-Kirches et al., Clin. Neuropathol. 16: 214-219, 1997; Ishizawa et al., Acta Neuropathol.(Berl) 97: 63-70, 1999]. This review discusses the possible role of autoantibodies and autoreactive T cells specific to neuronal antigens in SPS pathogenesis.
Similar articles
-
Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes.Diabetes Metab Res Rev. 2010 May;26(4):271-9. doi: 10.1002/dmrr.1083. Diabetes Metab Res Rev. 2010. PMID: 20503259 Free PMC article.
-
Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.J Exp Med. 1994 Aug 1;180(2):595-606. doi: 10.1084/jem.180.2.595. J Exp Med. 1994. PMID: 7519242 Free PMC article.
-
Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.J Autoimmun. 2011 Sep;37(2):79-87. doi: 10.1016/j.jaut.2011.05.005. Epub 2011 Jun 16. J Autoimmun. 2011. PMID: 21680149 Review.
-
GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence.Eur J Neurol. 2008 Sep;15(9):973-80. doi: 10.1111/j.1468-1331.2008.02221.x. Epub 2008 Jul 10. Eur J Neurol. 2008. PMID: 18637036
-
[Stiff-man syndrome from the perspective of internal medicine and immunology].Internist (Berl). 2000 May;41(5):460-6. doi: 10.1007/s001080050539. Internist (Berl). 2000. PMID: 10867902 Review. German. No abstract available.
Cited by
-
Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.PLoS One. 2010 May 26;5(5):e10838. doi: 10.1371/journal.pone.0010838. PLoS One. 2010. PMID: 20520773 Free PMC article.
-
High titers of autoantibodies to glutamate decarboxylase in type 1 diabetes patients: epitope analysis and inhibition of enzyme activity.Endocr Pract. 2013 Jul-Aug;19(4):663-8. doi: 10.4158/EP12318.OR. Endocr Pract. 2013. PMID: 23512385 Free PMC article.
-
Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats.Orphanet J Rare Dis. 2013 Jun 5;8:82. doi: 10.1186/1750-1172-8-82. Orphanet J Rare Dis. 2013. PMID: 23738610 Free PMC article.
-
Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia.Orphanet J Rare Dis. 2011 Feb 4;6:3. doi: 10.1186/1750-1172-6-3. Orphanet J Rare Dis. 2011. PMID: 21294897 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials